Antisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy

EMBO Molecular Medicine
Michael GramlichAlessandra Moretti

Abstract

Frameshift mutations in the TTN gene encoding titin are a major cause for inherited forms of dilated cardiomyopathy (DCM), a heart disease characterized by ventricular dilatation, systolic dysfunction, and progressive heart failure. To date, there are no specific treatment options for DCM patients but heart transplantation. Here, we show the beneficial potential of reframing titin transcripts by antisense oligonucleotide (AON)-mediated exon skipping in human and murine models of DCM carrying a previously identified autosomal-dominant frameshift mutation in titin exon 326. Correction of TTN reading frame in patient-specific cardiomyocytes derived from induced pluripotent stem cells rescued defective myofibril assembly and stability and normalized the sarcomeric protein expression. AON treatment in Ttn knock-in mice improved sarcomere formation and contractile performance in homozygous embryos and prevented the development of the DCM phenotype in heterozygous animals. These results demonstrate that disruption of the titin reading frame due to a truncating DCM mutation can be restored by exon skipping in both patient cardiomyocytes in vitro and mouse heart in vivo, indicating RNA-based strategies as a potential treatment option fo...Continue Reading

References

Dec 1, 2004·Proceedings of the National Academy of Sciences of the United States of America·Joseph M MianoRavi P Misra
Aug 15, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Martin M LeWinterHenk Granzier
Dec 28, 2007·The New England Journal of Medicine·Judith C van DeutekomGert-Jan B van Ommen
Mar 12, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Bo WuQi Long Lu
May 2, 2009·Journal of Molecular and Cellular Cardiology·Michael GramlichBrenda Gerull
Jul 30, 2009·Journal of Molecular and Cellular Cardiology·Martina Krüger, Wolfgang A Linke
Jun 17, 2010·Physiology·Wolfgang A Linke, Martina Krüger
Jul 28, 2010·The New England Journal of Medicine·Alessandra MorettiKarl-Ludwig Laugwitz
Mar 8, 2011·Nature Methods·Franz-Josef MüllerJeanne F Loring
Mar 19, 2011·Pflügers Archiv : European journal of physiology·Mathias Gautel
Mar 25, 2011·The New England Journal of Medicine·Nathalie M GoemansJudith C van Deutekom
Apr 16, 2011·Journal of the American College of Cardiology·Ray E Hershberger, Jill D Siegfried
Nov 15, 2011·Nature Reviews. Drug Discovery·Marica GrskovicGeorge Q Daley
Jan 10, 2012·Methods in Molecular Biology·Calvin T Hang, Ching-Pin Chang
Feb 4, 2012·Molecular & Cellular Proteomics : MCP·Christoph SchaabMatthias Mann
Feb 18, 2012·The New England Journal of Medicine·Daniel S HermanChristine E Seidman
Mar 29, 2012·Methods in Molecular Biology·Annemieke Aartsma-Rus
Mar 29, 2012·Methods in Molecular Biology·Aurélie Goyenvalle
Nov 13, 2012·Current Pharmaceutical Design·Corinne A Betts, Matthew J A Wood
May 30, 2013·EMBO Molecular Medicine·Christina Gedicke-HornungLucie Carrier
Aug 3, 2013·Annals of Neurology·Jerry R MendellUNKNOWN Eteplirsen Study Group
Mar 15, 2014·Circulation Research·Wolfgang A Linke, Nazha Hamdani
Jul 2, 2014·Human Mutation·Claire ChauveauAna Ferreiro
Jul 11, 2014·Nature Protocols·Li-Yu SungYu-Chen Hu
Sep 11, 2014·Biological Chemistry·Sebastian KötterMartina Krüger

❮ Previous
Next ❯

Citations

Dec 10, 2015·Expert Review of Cardiovascular Therapy·Paul F KantorSteven E Lipshultz
Jul 3, 2015·Expert Opinion on Biological Therapy·Dorota JeziorowskaJean-Sébastien Hulot
Nov 1, 2015·The Canadian Journal of Cardiology·Brenda Gerull
Mar 22, 2016·The Journal of Clinical Investigation·Elizabeth M McNally, Eugene J Wyatt
Jun 12, 2016·Nucleic Acids Research·Mallory A Havens, Michelle L Hastings
Sep 1, 2016·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Elham KayvanpourBenjamin Meder
Dec 15, 2017·Nature Reviews. Cardiology·James S Ware, Stuart A Cook
Apr 4, 2017·Clinical Genetics·M Sabater-MolinaJ R Gimeno
Jun 1, 2018·Human Gene Therapy·Tilman ZieglerChristian Kupatt
Aug 1, 2018·Expert Opinion on Biological Therapy·Tilman ZieglerChristian Kupatt
Sep 28, 2018·Current Cardiology Reports·Yiwen Fu, Howard J Eisen
Mar 4, 2017·Circulation Research·Timon SeegerJoseph C Wu
Jan 10, 2019·The Journal of Physiology·Lorenzo R Sewanan, Stuart G Campbell
Jan 27, 2019·Expert Review of Proteomics·Sandra MurphyKay Ohlendieck
Mar 29, 2019·Pflügers Archiv : European journal of physiology·Dalma KellermayerHenk Granzier
May 24, 2019·Circulation Research·Giuliana G RepettiChristine E Seidman
May 31, 2019·Journal of Muscle Research and Cell Motility·Amar AzadKatja Gehmlich
Oct 5, 2019·Disease Models & Mechanisms·Alexis R DemonbreunElizabeth M McNally
Oct 8, 2019·Circulation·Rebecca J ZaunbrecherCharles E Murry
May 8, 2020·Circulation Research·Antonio CannatàMauro Giacca
Nov 10, 2017·Journal of Muscle Research and Cell Motility·Mehroz EhsanKatja Gehmlich
Nov 14, 2017·Annual Review of Physiology·Wolfgang A Linke
Apr 27, 2019·American Journal of Physiology. Heart and Circulatory Physiology·Ali M TabishSakthivel Sadayappan
Sep 7, 2019·International Journal of Molecular Sciences·Andreas BrodehlHendrik Milting
Mar 18, 2020·European Cardiology·Alexandros Protonotarios, Perry M Elliott
Jun 25, 2020·International Journal of Molecular Sciences·Elvira Immacolata ParrottaGiovanni Cuda
May 21, 2020·Journal of Clinical Medicine·Weng-Tein GiBenjamin Meder
Jan 9, 2017·European Heart Journal·Ruben G de BruinEric P van der Veer
May 31, 2018·Journal of Cardiovascular Translational Research·Lingqun YeShijun Hu
May 8, 2018·Stem Cells International·Elda DzilicStefanie A Doppler
Oct 17, 2018·Pflügers Archiv : European journal of physiology·Thomas Eschenhagen, Lucie Carrier
May 15, 2020·International Journal of Molecular Sciences·Claudia SacchettoMartina Calore
Aug 23, 2019·Journal of the American Heart Association·Job A J VerdonschotStephane R B Heymans
Jan 9, 2021·PLoS Computational Biology·Wilson LouieDavid K Gifford
Feb 8, 2021·Experimental Cell Research·Narasimman GurusamyJohnson Rajasingh
Apr 4, 2021·Journal of Clinical Medicine·Ilaria My, Elisa Di Pasquale

❮ Previous
Next ❯

Methods Mentioned

BETA
antisense oligonucleotides
transfection
electron microscopy
Fluorescence
PCR

Software Mentioned

PluriTest
Perseus
GeneTools
MaxQuant

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.